Children with proven or suspected pulmonary TB or tuberculous meningitis caused by multidrug-resistant bacilli can be treated with a fluoroquinolone in the context of a well-functioning MDR-TB control programme and within an appropriate multidrug-resistant tuberculosis (MDR-TB) regimen. The decision to treat should be taken by a clinician experienced in managing paediatric TB